Comparison of clinical remission and survival between CLAG and FLAG induction chemotherapy in patients with refractory or relapsed acute myeloid leukemia: a prospective cohort study

PURPOSE: To compare the clinical remission and survival between CLAG and FLAG induction chemotherapy in treating patients with refractory or relapsed acute myeloid leukemia (R/R AML). METHODS: 103 R/R AML patients were consecutively enrolled in this prospective cohort study. 55 patients were treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Bao, Y., Zhao, J., Li, Z.-Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996008/
https://www.ncbi.nlm.nih.gov/pubmed/29181696
http://dx.doi.org/10.1007/s12094-017-1798-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996008/
https://www.ncbi.nlm.nih.gov/pubmed/29181696
http://dx.doi.org/10.1007/s12094-017-1798-8

Ejemplares similares